Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus propofol for deep sedation during EBUS-TBNA
ChiCTR2200061124Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine and propofol in None (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Dose of 1% lidocaine administered by bronchoscope. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
esketaminepropofol
Beyond the preview
Go deeper on ChiCTR2200061124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061124.